Research Application

The Duchenne Parent Project Netherlands (DPP NL) promotes research in the search for a cure for Duchenne Muscular Dystrophy. DPP NL sponsors promising research projects and fellowships, fast exchange of data and stimulates international collaboration. Researchers from all countries are invited to submit a research project to DPP NL.
Duchenne Parent Project NL has invested over 20 million euro in research towards viable treatments for Duchenne Muscular Dystrophy over the last 20 years.

Application Form

We are ready for a new round and are looking forward to receiving new applications starting from 1 February 2022. Please be aware that in 2022, we will ask you to first submit a pre-application with a brief description of your project. A full application will only be accepted after a positive review of the pre-application. The deadline for the pre-application is 1 April 2022.

Conditions for funding

Multi-track policy: we sponsor the widest possible range of research, including basic research, rehabilitation research, quality of life and genetic research.
Innovative research for finding a cure
Avoidance of diarchy in research
Results should be generally available and measurable
Research data should be Findable Accessible Interoperable and Reusable (FAIR).
Grant conditions will not be changed (click here for our contract)
Sponsored projects will be monitored closely and researchers are required to submit a progress report and final report
Final results should be published as soon as possible, in a peer reviewed open access scientific journal, also in the case of ‘negative’ results.
Based on the results of the progress report the Scientific Advisory Board advices DPP NL annually on the continuation of the sponsorship of the projects

Criteria

Projects should be in accordance with the aims of DPP NL
We encourage innovative projects
Both research projects and fellowships may be submitted
Funding will be for a maximum of two years
Maximum budget 100.000 euro
A PI can submit a maximum of two proposals
Please submit in English language
Give a brief description of the rationale and design of the experiments in language that is clear for reviewers outside the field
DPP NL does not fund overhead or VAT expenses
Project should start within one year after approval

Review procedure

From 1 February 2022 onwards we are open for new grant applications. The application procedure consists of two stages. Applicants must first submit a pre-application. If a pre-application is selected, the applicant will be invited to submit a full application in the second stage. The deadline for the pre-application is 1 April 2022.
First round selection by the board and the Scientific Advisory Board of DPP NL.
All applicants will be informed about the outcome of the first round selection. Selected applicants will receive an invitation to submit a full application. The deadline for full applications is 15 June 2022.
Second round selection by the board and the Scientific Advisory Board of DPP NL based on assessments by international reviewers.
Final decision by the board of DPP NL based on the advice of the Scientific Advisory Board.
Applicants will be informed about the outcome.

For further information, contact Michelle Reneerkens, research coordinator at research@duchenne.nl

Fast track application

We give you the opportunity to apply for smaller projects through the fast track procedure. This includes applications for workshops as well. For grant conditions, click here. The maximum budget is € 25.000. Deadlines for applications for this procedure quarterly at 1 January 2022, 1 April 2022, 1 July 2022 and 1 October 2022. Please send an email to research@duchenne.nl with a short description of your project.

Dr Imelda de Groot Award

The ‘Dr Imelda de Groot’ is annual award for a person, group or institution for the best project or achievement in the field of rehabilitation (in a broader sense) for Duchenne and Becker Muscular Dystrophy. This award is an initiative of the foundation Duchenne Parent Project, The Netherlands.

Dr Imelda de Groot retired in April 2021 as a pediatric rehabilitation specialist at the Radboud University Medical Center. During her career she initiated innovative and relevant research projects in the field of Duchenne and Becker Muscular Dystrophy, such as ‘No use is disuse’ about exercise and physical activities, outcome measures and many other subjects. The goal of the award is to stimulate researchers and clinicians to develop activities in this field. Candidates for this award can be nominated by Duchenne (and Becker) patient organizations around to globe. The winner of the award, selected by a jury existing of experts including patients, will receive € 10.000 to be spend on this type of research.